What's breaking now, across thousands of outlets.
When a breast screening raises questions, close coordination between specialists can help bring clarity and guide the next steps in care.
We haven't written up this one. Channel News Asia has the full story — the link below goes straight to it.
China’s edge in fast, cost-effective early clinical trials has propelled its emergence as a global biopharmaceutical powerhouse, but there is a risk that the United States could take steps to curb…
China’s edge in fast, cost-effective early clinical trials has propelled its emergence as a global biopharmaceutical powerhouse, but there is a risk that the United States could take steps to curb…
Former FSSAI chief Pawan Kumar Agarwal has urged the Supreme Court to consider a phased rollout of front-of-pack food warnings, warning that the proposed nutrient thresholds could place labels on more…
The failed samples during routine regulatory surveillance included 29 samples tested by the central drugs laboratories and 191 identified by the state drugs testing laboratories.
When the U.S. Food and Drug Administration (FDA) was deciding whether to approve the drug Tavneos several years ago to treat a set of rare autoimmune diseases, but agency experts argued that would be…
